Pure Global AI
ANVISA registration 10322250136Active

PLACENTAL ALPHA-1-MICROGLOBULIN (PAMG-1)

ANVISA Registration Number: 10322250136QIAGEN BIOTECNOLOGIA BRASIL LTDA.QIAGENRisk Class II
Verified
Device names
Technical name
PLACENTAL ALPHA-1-MICROGLOBULIN (PAMG-1)
View exact technical-name matches →
PT: ALFA-MICROGLOBULINA-1 PLACENTÁRIA (PAMG-1)
Commercial name
PartoSure Test
View exact commercial-name matches →
Risk class
Class II
Registration details
Registration Number
10322250136
Process Number
25351107594202596
CNPJ
01334250000120
Company information
Registration Holder
QIAGEN BIOTECNOLOGIA BRASIL LTDA.
Manufacturer
QIAGEN
Manufacturing Country
United States
PT: ESTADOS UNIDOS DA AMÉRICA
Dates and status
Publication Date
Aug 18, 2025
Validity
VIGENTE
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for PLACENTAL ALPHA-1-MICROGLOBULIN (PAMG-1) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10322250136 and manufactured by QIAGEN. The registration is held by QIAGEN BIOTECNOLOGIA BRASIL LTDA. with validity until currently active (VIGENTE).

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.